Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution
Delphine Denoyer, Helen B Pearson, Sharnel AS Clatworthy, Zoe M Smith, Paul S Francis, Roxana M Llanos, Irene Volitakis, Wayne A Phillips, Peter M Meggyesy, Shashank Masaldan, Michael A Cater
ONCOTARGET | IMPACT JOURNALS LLC | Published : 2016
This study was funded by Movember through Prostate Cancer Foundation of Australia's Research Program and by the CASS Foundation (M.A. Cater). H.B. Pearson was supported by a Movember/PCFA/cure cancer young investigator grant and a Richard Pratt Foundation Fellowship.